Array › Array

Drugs.com - Clinical Trials

Thu, 2009-11-12 16:29 — sciencestaff

Latest updates on trial results from clinical trials currently in progress.

Gloucester Pharmaceuticals to Present Positive Results from Multiple Studies of ISTODAX at the ASH Annual Meeting
Sucampo Announces Lubiprostone Data Presented at GASTRO 2009 UEGF/WCOG
Biovitrum (SE) - Kiobrina shows positive phase II results in preterm infants
Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
Caldolor (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients
AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer
CombinatoRx Oncology Programs to Be Highlighted at ASH 2009
Addex Pharmaceuticals (CH) - Addex ADX48621 Positive Primate Parkinson's Data
Nereus Pharmaceuticals Presents Positive Interim Data from the ADVANCE Study, a Randomized Phase 2 Clinical Trial of Plinabulin (NPI-2358) in Non-Small Cell Lung Cancer at the 2009 EORTC-NCI-AACR Conference
NexMed, Inc. to Acquire Bio-Quant, Inc.
Genfit: Extremely Promising Gft505 Results In Phase Ii
Nymox Releases Positive New Clinical Trial Data on Durability of Benefits for Early Responders to Company?s BPH Drug NX-1207
Chiesi Is Top Italian Pharmaceutical Group for Investment In Research
Biotec Pharmacon ASA (NO) - Phase III Results With SBG for Diabetic Foot Ulcer Not Positive
Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009
Isis Pharmaceuticals (Nasdaq: ISIS) Letter to Shareholders
Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
Pronova BioPharma ASA (NO) - Pronova BioPharma ASA presented at "Aksjedagen Norge" 2009
Merck KGaA to Expand Research and Development Presence in China
Genasense® Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma

More on Sciencestage.com